Unique ID issued by UMIN | UMIN000036743 |
---|---|
Receipt number | R000041868 |
Scientific Title | Phase II study of image-guided proton therapy for solitary primary hepatocellular carcinoma with indication for standard treatment |
Date of disclosure of the study information | 2019/05/20 |
Last modified on | 2021/04/12 22:17:04 |
Phase II study of image-guided proton therapy for solitary primary hepatocellular carcinoma with indication for standard treatment
Phase II study of image-guided proton therapy for solitary primary hepatocellular carcinoma with indication for standard treatment
Phase II study of image-guided proton therapy for solitary primary hepatocellular carcinoma with indication for standard treatment
Phase II study of image-guided proton therapy for solitary primary hepatocellular carcinoma with indication for standard treatment
Japan |
solitary primary hepatocellular carcinoma
Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery | Radiology |
Malignancy
NO
To evaluate the efficacy and safety of image-guided proton therapy for solitary primary hepatocellular carcinoma that was amenable to standard treatment (resection or ablation)
Safety,Efficacy
2-year overall survival
local control rate, progression free survival,response rate,incidence of grade 3 or higher adverse events,change of quality of life (QOL)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Other |
image-guided proton therapy
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1) histologically-confirmed or image-diagnosed solitary primary HCC staged as T1N0M0 (UICC TNM 7th ed.)
2) no history of previous HCC
3) patient refusal of surgery or radiofrequency ablation
4) no previous radiotherapy around the lesion
5) age: 20-80 years old
6) ECOG-PS: 0-1
7) Child-Pugh classification A5, 6 or B7
8) dose constraints of the organs at risk achievable
9) tumor diameter < 12 cm
10) written informed consent
1)pregnancy or lactation
2)severe psychological disorders
3)active and uncontrolled infection
4)Other cancers within 5 years
5)continuous systemic administration (oral or intravenous) of steroids
6)esophageal varix at high risk of bleeding (F3, Rc ++ or higher)
7)portal vein tumor thrombosis
8)cases in which the doctor is judged inappropriate for medical, psychological or other reasons other than the above
45
1st name | Hiroyuki |
Middle name | |
Last name | Ogino |
Nagoya City West Medical Center,Nagoya Proton Therapy Center
Radiation oncology
462-8508
1-1-1 Hirate-cho, Kita-ku, Nagoya-city, Aichi-prefecture
052-991-8577
oginogio@gmail.com
1st name | Hiromitsu |
Middle name | |
Last name | Iwata |
Nagoya City West Medical Center,Nagoya Proton Therapy Center
Radiation oncology
462-8508
1-1-1 Hirate-cho, Kita-ku, Nagoya-city, Aichi-prefecture
052-991-8577
h-iwa-ncu@nifty.com
Nagoya City West Medical Center
Nagoya City West Medical Center,Nagoya Proton Therapy Center
Self funding
Clinical Study Committees of the Nagoya City Hospital
1-2-23 Wakamizu, Chikusa-ku, Nagoya-city, Aichi-prefecture
052-721-7171
rinsho1@higashi-hosp.jp
NO
2019 | Year | 05 | Month | 20 | Day |
Unpublished
45
Completed
2013 | Year | 03 | Month | 28 | Day |
2013 | Year | 03 | Month | 19 | Day |
2013 | Year | 06 | Month | 15 | Day |
2019 | Year | 09 | Month | 30 | Day |
2019 | Year | 12 | Month | 31 | Day |
2019 | Year | 05 | Month | 14 | Day |
2021 | Year | 04 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041868